Pharma Focus Asia

Repligen

LATEST NEWSRead more...

20

Jun 2024

Golidocitinib Receives Approval in China as the First JAK1-Selective Inhibitor for Treating Relapsed or Refractory Peripheral T-Cell Lymphoma

Dizal a biopharmaceutical company dedicated to developing new treatments for cancer and immunological diseases announced that golidocitinib has received approval from the National Medical Products

20

Jun 2024

Roche Launches New Test for Early Detection of B-cell Lymphoma

Roche has recently launched the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay the first ISH test approved for clinical use in countries that accept the CE Mark This assay aids pathologists in distinguishing between Bcell malignancies and normal immune responses to infections

19

Jun 2024

Junshi Biosciences Gains Approval for sNDA of Toripalimab as First-Line Therapy for Small Cell Lung Cancer

Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on developing innovative therapies announced that the National Medical Products

19

Jun 2024

Ionis and Otsuka Expand Licensing Agreement for Hereditary Angioedema Drug Donidalorsen in Asia Pacific

Ionis Pharmaceuticals Inc has finalized a licensing agreement with Otsuka Pharmaceutical Co Ltd granting Otsuka exclusive rights to donidalorsen in the AsiaPacific region

19

Jun 2024

Spyre Therapeutics Initiates Phase 1 Study of SPY001, a Novel Antibody Targeting α4β7 for Inflammatory Bowel Disease Therapy

Spyre Therapeutics Inc a biotechnology firm focused on the development of innovative treatments for Inflammatory Bowel Disease has announced the initiation of its first clinical trial

Solovpe

press releasesRead more...

20

Jun 2024

GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group

GC Cell a fully integrated cell and gene therapy pioneer is proud to announce the establishment of an MOU for strategic partnership with Bifarma a frontrunner in stem cell therapy within Indonesia with comprehensive capabilities

20

Jun 2024

Medivir Selects Global CRO Partner for Upcoming Phase 2b Study in HCC With Fostrox + Lenvima and Initiates Study Feasibility

Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that it has selected a global

20

Jun 2024

Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

Recently Professor Jianping Weng of the University of Science and Technology of China and President of Anhui Medical University and his team of researchers from USTC Southern Medical University

19

Jun 2024

Menarini Asia-Pacific partners with Pharmacosmos to expand its reach of MonoFer® to Singapore and Malaysia

Menarini AsiaPacific today announced that it has expanded its partnership with Pharmacosmos AS to include exclusive rights to commercialise MonoFer

19

Jun 2024

Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally

Singleron Biotechnologies announced a partnership with the Human Cell Atlas to help accelerate the adoption of single cell sequencing globally Singleron will facilitate access

19

Jun 2024

YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China

YolTech a clinicalstage biopharmaceutical company specializing in mRNALNP delivery for in vivo gene editing therapies has partnered with KACTUS a leading developer serving the biopharmaceutical industry

18 - 20

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

19 - 20

Jun 2024

LogiPharma Asia 2024

Equarius Hotel, Singapore

19 - 21

Jun 2024

CPHI & PMEC 2024

Shanghai, China

20 - 22

Jun 2024

20 - 22

Jun 2024

24 - 24

Jun 2024

24 - 25

Jun 2024

25 - 26

Jun 2024

Asia Healthcare Week (AHW)

Suntec Convention & Exhibition Centre, Singapore

magazine-slider-image
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI China || PMEC China 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 1

    The Emergence of Organ-on-chips for Diseases Studies and Drug Development

    Giuseppe Maruccio

    Full Professor, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Anna Grazia Monteduro

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec, and INFN-Lecce

    Silvia Rizzato

    Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

    Giusi Caragnano

    PhD Student, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce

  • 2

    Meet scientist Daria Donati

    Daria Donati

    Head of Business Development Bioprocess & Director of Global Strategic Technology Partnership, Cytiva

  • 4

    Nano-Carrier based Smart Drug Delivery Systems

    Sidharth Mehta

    Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology

    Nikita Yadav

    Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology

KNOWLEDGE BANK

  • Interviews

    Thomson Reuters

    Senior Vice President

    We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry
  • Articles

    How Ready are Cellulose Nanocrystals in Delivery of Anticanceragents?

    Despite the contemporary medical and life care evolution cancer pathologies still claim high ranks in the outline of the st centurys globally scary diseases to populations inclusive of patients health professionals research specialists and authorities As an initiation by altered and mutated normal cells that lead to uncontrolled cell proliferation

  • White Papers

    Destination India: Reconfiguring Gelatin Value Chain

    Bovine Gelatin Industry Overview The global gelatin production in was thousand tons which is expected to grow at a CAGR of till Globally of gelatin is bovine bone based The yield conversion factor from bovine bone chips to gelatin is Bovine bone chips are widely used to manufacture pharmaceutical gelatin since it is more preferred due to its encapsulation properties and higher bl

EDITORIAL SECTION